Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Zhaoyang Li & Rachael Easton. (2018) Practical considerations in clinical strategy to support the development of injectable drug-device combination products for biologics. mAbs 10:1, pages 18-33.
Read now
Read now
M. Valentini, M. Scardapane, F. Bondanini, A. Bossi, A. Colatrella, A. Girelli, A. Ciucci, S. Leotta, E. Minotti, F. Pasotti, A. Pesenti, L. Rocca, L. Sciangula, E. Vavassori & A. Nicolucci. (2015) Efficacy, safety and acceptability of the new pen needle 33G × 4 mm. AGO 01 study. Current Medical Research and Opinion 31:3, pages 487-492.
Read now
Read now
Michael Grabner, James Chu, Swetha Raparla, Ralph Quimbo, Steve Zhou & Joseph Conoshenti. (2013) Clinical and Economic Outcomes Among Patients With Diabetes Mellitus Initiating Insulin Glargine Pen Versus Vial. Postgraduate Medicine 125:3, pages 204-213.
Read now
Read now
David Oyer, Marcus Niemeyer & Alan Moses. (2012) Empowering People with Diabetes: Improving Perceptions and Outcomes with Technical Advances in Insulin Pens. Postgraduate Medicine 124:5, pages 110-120.
Read now
Read now
Carlos Campos, Rosemarie Lajara & Tony Deluzio. (2012) Usability and preference assessment of a new prefilled insulin pen versus vial and syringe in people with diabetes, physicians and nurses. Expert Opinion on Pharmacotherapy 13:13, pages 1837-1846.
Read now
Read now
Christina Schipper, Petra Musholt, Marcus Niemeyer, Marianne Qvist, Andrea Löffler, Thomas Forst & Andreas Pfützner. (2012) Patient device assessment evaluation of two insulin injection devices in a mixed cohort of insulin-treated patients with type 1 or type 2 diabetes mellitus. Current Medical Research and Opinion 28:8, pages 1297-1303.
Read now
Read now
Daniel A. Nadeau, Carlos Campos, Marcus Niemeyer & Timothy Bailey. (2012) Healthcare professional and patient assessment of a new prefilled insulin pen versus two widely available prefilled insulin pens for ease of use, teaching and learning. Current Medical Research and Opinion 28:1, pages 3-13.
Read now
Read now
Kate Van Brunt, Louis S Matza, Peter M Classi & Joseph A Johnston. (2011) Preferences related to attention-deficit/hyperactivity disorder and its treatment. Patient Preference and Adherence 5, pages 33-43.
Read now
Read now
Sherwyn L Schwartz, Debra A Ignaut & Jennifer N Bodie. (2010) Humalog® KwikPen™: an insulin-injecting pen designed for ease of use. Expert Review of Medical Devices 7:6, pages 735-743.
Read now
Read now
Laurence J. Hirsch, Michael A. Gibney, John Albanese, Shankang Qu, Kenneth Kassler-Taub, Leslie J. Klaff & Timothy S. Bailey. (2010) Comparative glycemic control, safety and patient ratings for a new 4 mm × 32G insulin pen needle in adults with diabetes. Current Medical Research and Opinion 26:6, pages 1531-1541.
Read now
Read now
Alessandra Lugaresi. (2009) Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation?. Expert Opinion on Drug Delivery 6:9, pages 995-1002.
Read now
Read now
T Asakura, H Seino, M Kageyama & N Yohkoh. (2009) Evaluation of injection force of three insulin delivery pens. Expert Opinion on Pharmacotherapy 10:9, pages 1389-1393.
Read now
Read now
Alex Z. Fu, Ying Qiu & Larry Radican. (2009) Impact of fear of insulin or fear of injection on treatment outcomes of patients with diabetes. Current Medical Research and Opinion 25:6, pages 1413-1420.
Read now
Read now
Andreas Pfützner. (2009) FlexPen® for the delivery of insulin: accuracy, injection force and patient preference. Expert Review of Medical Devices 6:2, pages 115-123.
Read now
Read now
A. Pfützner, T. Reimer, C. Hohberg, L. P. F. Frøkjær & C. Jørgensen. (2008) Prefilled insulin device with reduced injection force: patient perception and accuracy. Current Medical Research and Opinion 24:9, pages 2545-2549.
Read now
Read now
A Pfützner, T Asakura, B Sommavilla & WC Lee. (2008) Insulin delivery with FlexPen®: dose accuracy, patient preference and adherence. Expert Opinion on Drug Delivery 5:8, pages 915-925.
Read now
Read now
Mark Peyrot & Richard R. Rubin. (2008) Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus. Current Medical Research and Opinion 24:8, pages 2413-2422.
Read now
Read now
Debra A Ignaut & Willem JRR Venekamp. (2007) HumaPen® Memoir™: a novel insulin-injecting pen with a dose-memory feature. Expert Review of Medical Devices 4:6, pages 793-802.
Read now
Read now
Articles from other publishers (39)
Sandro Gentile, Giuseppina Guarino, Teresa Della Corte, Giampiero Marino, Ersilia Satta, Carmine Romano, Carmelo Alfrone, Clelia lmberti & Felice Strollo. (2021) Bruising: A Neglected, Though Patient-Relevant Complication of Insulin Injections Coming to Light from a Real-Life Nationwide Survey. Diabetes Therapy.
Crossref
Crossref
Colin H. Ridyard, Dalia M. M. Dawoud, Lorna V. Tuersley & Dyfrig A. Hughes. (2016) A Systematic Review of Patients’ Perspectives on the Subcutaneous Route of Medication Administration. The Patient - Patient-Centered Outcomes Research 9:4, pages 281-292.
Crossref
Crossref
Danny D Meetoo. (2016) Insulin: An evolving paradigm in diabetes management. Practice Nursing 27:Sup3, pages 11-16.
Crossref
Crossref
Susan LaRue & Jaret Malloy. (2015) Evaluation of the Dual-Chamber Pen Design for the Injection of Exenatide Once Weekly for the Treatment of Type 2 Diabetes. Journal of Diabetes Science and Technology 9:4, pages 815-821.
Crossref
Crossref
Andrew AhmannSheryl L. SzeinbachJasvinder GillLouise TraylorSatish K. Garg. (2014) Comparing Patient Preferences and Healthcare Provider Recommendations with the Pen Versus Vial-and-Syringe Insulin Delivery in Patients with Type 2 Diabetes. Diabetes Technology & Therapeutics 16:2, pages 76-83.
Crossref
Crossref
Robert M. Cuddihy & Sarah K. Borgman. (2013) Considerations for Diabetes. American Journal of Therapeutics 20:6, pages 694-702.
Crossref
Crossref
Susan M. Joy, Emily Little, Nisa M. Maruthur, Tanjala S. Purnell & John F. P. Bridges. (2013) Patient Preferences for the Treatment of Type 2 Diabetes: A Scoping Review. PharmacoEconomics 31:10, pages 877-892.
Crossref
Crossref
Danny D Meetoo. (2013) Insulin: an evolving paradigm in diabetes management. British Journal of Healthcare Management 19:Sup1, pages 8-15.
Crossref
Crossref
Takashi MiwaRokuro ItohTakaaki KobayashiTakashi TanabeJunpei ShikumaTomono TakahashiMasato Odawara. (2012) Comparison of the Effects of a New 32-Gauge×4-mm Pen Needle and a 32-Gauge×6-mm Pen Needle on Glycemic Control, Safety, and Patient Ratings in Japanese Adults with Diabetes. Diabetes Technology & Therapeutics 14:12, pages 1084-1090.
Crossref
Crossref
Irving GottesmanPatrice PerronLori BerardJohn StewartNils BassoKim MettimanoThomas Elliott. (2012) Evaluation of a New Reusable Insulin Pen (ClikSTAR) in Canadian Patients with Type 1 and Type 2 Diabetes Mellitus Receiving Insulin Glargine. Diabetes Technology & Therapeutics 14:10, pages 926-935.
Crossref
Crossref
Kellie J. Antinori-Lent. (2012) Analysis of Comparison of Patient Preference for Two Insulin Injection Pen Devices in Relation to Patient Dexterity Skills. Journal of Diabetes Science and Technology 6:4, pages 917-920.
Crossref
Crossref
Danny MeetooGillian McAllister, Adele West & Mandy Turnbull. (2012) In pursuit of excellence in diabetes care: trends in insulin delivery. British Journal of Nursing 21:10, pages 588-595.
Crossref
Crossref
Burkhard Ludescher, Marc Rommel, Tobias Willmer, Andreas Fritsche, Fritz Schick & Juergen Machann. (2011) Subcutaneous adipose tissue thickness in adults - correlation with BMI and recommendations for pen needle lengths for subcutaneous self-injection. Clinical Endocrinology 75:6, pages 786-790.
Crossref
Crossref
Barbara J. AndersonMaria J. Redondo. (2011) What Can We Learn from Patient-Reported Outcomes of Insulin Pen Devices?. Journal of Diabetes Science and Technology 5:6, pages 1563-1571.
Crossref
Crossref
Nancy BohannonRichard BergenstalRobert CuddihyDavida KrugerSusan ListElaine MassaroMark MolitchPhilip RaskinHeather RemtemaSuzanne StrowigFred WhitehouseRocco L. BrunelleDarlene DreonMeng Tan. (2011) Comparison of a Novel Insulin Bolus-Patch with Pen/Syringe Injection to Deliver Mealtime Insulin for Efficacy, Preference, and Quality of Life in Adults with Diabetes: A Randomized, Crossover, Multicenter Study. Diabetes Technology & Therapeutics 13:10, pages 1031-1037.
Crossref
Crossref
Ragnar Hanas, Carine de Beaufort, Hilary Hoey & Barbara Anderson. (2011) Insulin delivery by injection in children and adolescents with diabetes. Pediatric Diabetes 12:5, pages 518-526.
Crossref
Crossref
Mark PeyrotRichard R. Rubin. (2011) Factors Associated with Persistence and Resumption of Insulin Pen Use for Patients with Type 2 Diabetes. Diabetes Technology & Therapeutics 13:1, pages 43-48.
Crossref
Crossref
Jayne Hodgkiss. (2010) Incretin-based therapies for type 2 diabetes: a nurse’s perspective. British Journal of Nursing 19:21, pages 1337-1344.
Crossref
Crossref
Birthe S. Olsen, Søren Kruse Lilleøre, Conny Nøhr Korsholm & Thorben Kracht. (2010) Novopen Echo® for the Delivery of Insulin: A Comparison of Usability, Functionality and Preference among Pediatric Subjects, Their Parents, and Health Care Professionals. Journal of Diabetes Science and Technology 4:6, pages 1468-1475.
Crossref
Crossref
. (2010) Comment on “The Broken Pen Penalty” (Lakshmanadoss et al.). Diabetes Technology & Therapeutics 12:11, pages 929-930.
Crossref
Crossref
Susan Cornell. (2010) Managing diabetes-related costs and quality of life issues: Value of insulin analogs and pens for inpatient use. Health Policy 96:3, pages 191-199.
Crossref
Crossref
A. N. Naegeli & R. P. Hayes. (2010) Expectations about and experiences with insulin therapy contribute to diabetes treatment satisfaction in insulin-naïve patients with type 2 diabetes. International Journal of Clinical Practice 64:7, pages 908-916.
Crossref
Crossref
Kiyomi MasudaKazutaka AokiKaori KikuchiUru NezuTomonori MuraokaKazuaki ShinodaAkinobu NakamuraMakoto ShibuyaMayumi TakahashiMari KimuraYasuo Terauchi. (2010) Self-Injection of Insulin Using Appropriate Supportive Devices in Handicapped Subjects with Diabetes. Diabetes Technology & Therapeutics 12:6, pages 483-490.
Crossref
Crossref
David S. Cobden, Louis W. Niessen, Charles E. Barr, Frans F.H. Rutten & W. Ken Redekop. (2010) Relationships among Self-Management, Patient Perceptions of Care, and Health Economic Outcomes for Decision-Making and Clinical Practice in Type 2 Diabetes. Value in Health 13:1, pages 138-147.
Crossref
Crossref
Lisa Kroon. (2009) An Analysis of Patient Acceptance and Safety of a Prefilled Insulin Injection Device. Journal of Diabetes Science and Technology 3:6, pages 1439-1441.
Crossref
Crossref
Lisa Kroon. (2009) Overview of insulin delivery pen devices. Journal of the American Pharmacists Association 49:5, pages e118-e131.
Crossref
Crossref
Debra A. Ignaut, Sherwyn L. Schwartz, Samiha Sarwat & Heather L. Murphy. (2009) Comparative Device Assessments. The Diabetes Educator 35:5, pages 789-798.
Crossref
Crossref
Cliff MolifeLauren J. LeeLizheng ShiMonika SawhneySheila M. Lenox. (2009) Assessment of Patient-Reported Outcomes of Insulin Pen Devices Versus Conventional Vial and Syringe. Diabetes Technology & Therapeutics 11:8, pages 529-538.
Crossref
Crossref
Risa P. HayesJames T. Fitzgerald. (2009) Perceptions and Attitudes Are Primary Contributors to Insulin Delivery System Satisfaction in People with Type 2 Diabetes. Diabetes Technology & Therapeutics 11:7, pages 419-426.
Crossref
Crossref
Amna A. ShaghouliBaiju R. Shah. (2009) The Prescription of Insulin Pen Devices Versus Syringes for Older People with Diabetes. Diabetes Technology & Therapeutics 11:7, pages 439-442.
Crossref
Crossref
Charles F. ShaeferJr.Jr.. (2009) The pen is mightier than the sword. Insulin 4:3, pages 132-135.
Crossref
Crossref
Norbert HermannsBernhard KulzerThomas Haak. (2008)
Dosing Accuracy with a Novel Pen Device (SoloSTAR
®
) as Performed by Patients with Diabetes in a Clinical Setting
. Diabetes Technology & Therapeutics 10:4, pages 322-327.
Crossref
Crossref
C. Bradley & C. J. B. Gilbride. (2008) Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine. Diabetes, Obesity and Metabolism 10:s2, pages 50-65.
Crossref
Crossref
. (2008) Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 15:2, pages 193-219.
Crossref
Crossref
Richard R. Rubin & Mark Peyrot. (2008) Factors Affecting Use of Insulin Pens by Patients With Type 2 Diabetes. Diabetes Care 31:3, pages 430-432.
Crossref
Crossref
Ernest Asamoah. (2008) Insulin Pen—The “iPod” for Insulin Delivery (Why Pen Wins over Syringe). Journal of Diabetes Science and Technology 2:2, pages 292-296.
Crossref
Crossref
Martha M. Funnell. (2008) Quality of Life and Insulin Therapy in Type 2 Diabetes Mellitus. Insulin 3:1, pages 31-36.
Crossref
Crossref
Michael A. Magnolti & Elliot J. Rayfield. (2007) An Update on Insulin Injection Devices. Insulin 2:4, pages 173-181.
Crossref
Crossref
David Cobden, Won Chan Lee, Sanjeev Balu, Ashish V Joshi & Chris L Pashos. (2007) Health Outcomes and Economic Impact of Therapy Conversion to a Biphasic Insulin Analog Pen Among Privately Insured Patients with Type 2 Diabetes Mellitus. Pharmacotherapy 27:7, pages 948-962.
Crossref
Crossref